| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.59 | 1-year : | 0.66 |
| Resists | First : | 0.51 | Second : | 0.56 |
| Pivot price | 0.45 |
|||
| Supports | First : | 0.41 | Second : | 0.34 |
| MAs | MA(5) : | 0.45 |
MA(20) : | 0.46 |
| MA(100) : | 0.45  |
MA(250) : | 1.13 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 16.8 |
D(3) : | 22 |
| RSI | RSI(14): 43.2 |
|||
| 52-week | High : | 2.81 | Low : | 0.28 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HBIO ] has closed above bottom band by 32.0%. Bollinger Bands are 62.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.45 - 0.45 | 0.45 - 0.46 |
| Low: | 0.42 - 0.43 | 0.43 - 0.43 |
| Close: | 0.44 - 0.44 | 0.44 - 0.45 |
Tue, 16 Sep 2025
Harvard Bioscience Expands U.S. Distribution Agreement with Fisher Scientific to Enhance Access to Laboratory Equipment - Quiver Quantitative
Tue, 16 Sep 2025
Major Lab Equipment Distribution Deal: Harvard Bioscience Teams with Fisher Scientific Across US Market - Stock Titan
Thu, 14 Aug 2025
Harvard Bioscience, Inc. (NASDAQ:HBIO) Just Reported, And Analysts Assigned A US$3.00 Price Target - simplywall.st
Mon, 11 Aug 2025
HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Quiver Quantitative
Mon, 11 Aug 2025
Harvard Bioscience Q2 Earnings: Revenue Beats Guidance as New CEO Charts Turnaround Path - Stock Titan
Fri, 08 Aug 2025
Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 45 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 10 (%) |
| Held by Institutions | 54.7 (%) |
| Shares Short | 757 (K) |
| Shares Short P.Month | 1,320 (K) |
| EPS | -1.29 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.34 |
| Profit Margin | -64.7 % |
| Operating Margin | -3.1 % |
| Return on Assets (ttm) | -2 % |
| Return on Equity (ttm) | -138.4 % |
| Qtrly Rev. Growth | -11.5 % |
| Gross Profit (p.s.) | 1.13 |
| Sales Per Share | 1.99 |
| EBITDA (p.s.) | 0.07 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 7 (M) |
| Levered Free Cash Flow | 10 (M) |
| PE Ratio | -0.35 |
| PEG Ratio | 0 |
| Price to Book value | 1.26 |
| Price to Sales | 0.22 |
| Price to Cash Flow | 2.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|